Phenotypic Characterization of Retinoic Acid Differentiated SH-SY5Y Cells by Transcriptional Profiling

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Korecka, Joanna A ^a   van Kesteren, Ronald E ^b   Blaas, Eva ^b   Spitzer, Sonia O ^a,d   Kamstra, Jorke H ^c   Smit, August B ^b   Swaab, Dick F ^a   Verhaagen, Joost ^a,b   Bossers, Koen ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c INSTITUTE FOR ENVIRONMENTAL STUDIES   (Netherlands)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MICROSCOPY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PHENOTYPE; PROTEIN EXPRESSION; SH SY5Y CELL; SIGNAL TRANSDUCTION; UPREGULATION;

1-METHYL-4-PHENYLPYRIDINIUM; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINERGIC NEURONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; SUBSTANTIA NIGRA; TRETINOIN;

EID: 84878411147     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063862     Document Type: Article

References (68)

1. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39: 889-909. S0896627303005683 [pii].
2. Nikolaus S, Antke C, Muller HW, (2009) In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders. Behav Brain Res 204: 32-66 S0166-4328(09)00355-6 [pii];10.1016/j.bbr.2009.06.009 [doi].
3. Olanow CW, Stern MB, Sethi K, (2009) The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 72: S1-136 72/21_Supplement_4/S1 [pii];10.1212/WNL.0b013e3181a1d44c [doi].
4. Bonifati V, (2007) Genetics of parkinsonism. Parkinsonism Relat Disord 13Suppl 3: S233-S241 S1353-8020(08)70008-7 [pii];10.1016/S1353-8020(08)70008-7 [doi].
5. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259 10.1126/science.1077209 [doi];1077209 [pii].
6. Gorell JM, Peterson EL, Rybicki BA, Johnson CC (2004) Multiple risk factors for Parkinson's disease. J Neurol Sci 217: 169-174. S0022510X03002892 [pii].
7. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J, (2011) Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol 26Suppl 1: S1-58 10.1007/s10654-011-9581-6 [doi].
8. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, et al. (1997) Alpha-synuclein in Lewy bodies. Nature 388: 839-840 10.1038/42166 [doi].
9. Braak H, Del TK, Rub U, de Vos RA, Jansen Steur EN, et al. (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197-211. S0197458002000659 [pii].
10. Greenamyre JT, Hastings TG, (2004) Biomedicine. Parkinson's-divergent causes, convergent mechanisms. Science 304: 1120-1122 10.1126/science.1098966 [doi];304/5674/1120 [pii].
11. Grunblatt E, Mandel S, Jacob-Hirsch J, Zeligson S, Amariglo N, et al. (2004) Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm 111: 1543-1573 10.1007/s00702-004-0212-1 [doi].
12. Mandel S, Grunblatt E, Riederer P, Amariglio N, Jacob-Hirsch J, et al. (2005) Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. Ann N Y Acad Sci 1053: 356-375 1053/1/356 [pii];10.1196/annals.1344.031 [doi].
13. Miller RM, Kiser GL, Kaysser-Kranich TM, Lockner RJ, Palaniappan C, et al. (2006) Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease. Neurobiol Dis 21: 305-313 S0969-9961(05)00209-3 [pii];10.1016/j.nbd.2005.07.010 [doi].
14. Hauser MA, Li YJ, Xu H, Noureddine MA, Shao YS, et al. (2005) Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Arch Neurol 62: 917-921 62/6/917 [pii];10.1001/archneur.62.6.917 [doi].
15. Lewandowski NM, Ju S, Verbitsky M, Ross B, Geddie ML, et al. (2010) Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proc Natl Acad Sci U S A 107: 16970-16975 1011751107 [pii];10.1073/pnas.1011751107 [doi].
16. Moran LB, Duke DC, Deprez M, Dexter DT, Pearce RK, et al. (2006) Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease. Neurogenetics 7: 1-11 10.1007/s10048-005-0020-2 [doi].
17. Simunovic F, Yi M, Wang Y, Macey L, Brown LT, et al. (2009) Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology. Brain 132: 1795-1809 awn323 [pii];10.1093/brain/awn323 [doi].
18. Zhang Y, James M, Middleton FA, Davis RL, (2005) Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet 137B: 5-16 10.1002/ajmg.b.30195 [doi].
19. Bossers K, Meerhoff G, Balesar R, van Dongen JW, Kruse CG, et al. (2009) Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol 19: 91-107 BPA171 [pii];10.1111/j.1750-3639.2008.00171.x [doi].
20. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS, (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38: 3751-3757.
21. Cheung YT, Lau WK, Yu MS, Lai CS, Yeung SC, et al. (2009) Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 30: 127-135 S0161-813X(08)00200-3 [pii];10.1016/j.neuro.2008.11.001 [doi].
22. Conn KJ, Ullman MD, Larned MJ, Eisenhauer PB, Fine RE, et al. (2003) cDNA microarray analysis of changes in gene expression associated with MPP+ toxicity in SH-SY5Y cells. Neurochem Res 28: 1873-1881.
23. Brill LB, Bennett JP, Jr. (2003) Dependence on electron transport chain function and intracellular signaling of genomic responses in SH-SY5Y cells to the mitochondrial neurotoxin MPP(+). Exp Neurol 181: 25-38. S0014488602000456 [pii].
24. Ding Q, Bruce-Keller AJ, Chen Q, Keller JN, (2004) Analysis of gene expression in neural cells subject to chronic proteasome inhibition. Free Radic Biol Med 36: 445-455 10.1016/j.freeradbiomed.2003.10.025 [doi];S0891584903007494 [pii].
25. Kaplan DR, Matsumoto K, Lucarelli E, Thiele CJ (1993) Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Eukaryotic Signal Transduction Group. Neuron 11: 321-331. 0896-6273(93)90187-V [pii].
26. Cuende J, Moreno S, Bolanos JP, Almeida A, (2008) Retinoic acid downregulates Rae1 leading to APC(Cdh1) activation and neuroblastoma SH-SY5Y differentiation. Oncogene 27: 3339-3344 1210987 [pii];10.1038/sj.onc.1210987 [doi].
27. Miloso M, Villa D, Crimi M, Galbiati S, Donzelli E, et al. (2004) Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent. J Neurosci Res 75: 241-252 10.1002/jnr.10848 [doi].
28. Rossino P, Defilippi P, Silengo L, Tarone G, (1991) Up-regulation of the integrin alpha 1/beta 1 in human neuroblastoma cells differentiated by retinoic acid: correlation with increased neurite outgrowth response to laminin. Cell Regul 2: 1021-1033.
29. Pan J, Kao YL, Joshi S, Jeetendran S, Dipette D, et al. (2005) Activation of Rac1 by phosphatidylinositol 3-kinase in vivo: role in activation of mitogen-activated protein kinase (MAPK) pathways and retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J Neurochem 93: 571-583 JNC3106 [pii];10.1111/j.1471-4159.2005.03106.x [doi].
30. Truckenmiller ME, Vawter MP, Cheadle C, Coggiano M, Donovan DM, et al. (2001) Gene expression profile in early stage of retinoic acid-induced differentiation of human SH-SY5Y neuroblastoma cells. Restor Neurol Neurosci 18: 67-80.
31. Lopez-Carballo G, Moreno L, Masia S, Perez P, Barettino D, (2002) Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem 277: 25297-25304 10.1074/jbc.M201869200 [doi];M201869200 [pii].
32. Kito K, Ito T, Sakaki Y (1997) Fluorescent differential display analysis of gene expression in differentiating neuroblastoma cells. Gene 184: 73-81. S0378-1119(96)00577-X [pii].
33. Lopes FM, Schroder R, da Frota MLJ, Zanotto-Filho A, Muller CB, et al. (2010) Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res 1337: 85-94 S0006-8993(10)00765-1 [pii];10.1016/j.brainres.2010.03.102 [doi].
34. Zimmermann M, Gardoni F, Marcello E, Colciaghi F, Borroni B, et al. (2004) Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines. J Neurochem 90: 1489-1499 10.1111/j.1471-4159.2004.02680.x [doi];JNC2680 [pii].
35. Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, et al. (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46: 598-605.
36. Pifl C, Hornykiewicz O, Giros B, Caron MG, (1996) Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter. J Pharmacol Exp Ther 277: 1437-1443.
37. Nakamura K, Bindokas VP, Marks JD, Wright DA, Frim DM, et al. (2000) The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited. Mol Pharmacol 58: 271-278.
38. Lotharius J, O'Malley KL, (2000) The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem 275: 38581-38588 10.1074/jbc.M005385200 [doi];M005385200 [pii].
39. Nicotra A, Parvez S (2002) Apoptotic molecules and MPTP-induced cell death. Neurotoxicol Teratol 24: 599-605. S0892036202002131 [pii].
40. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, et al. (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28: 264-278 28/1/264 [pii];10.1523/JNEUROSCI.4178-07.2008 [doi].
41. Kurimoto K, Saitou M, (2010) Single-cell cDNA microarray profiling of complex biological processes of differentiation. Curr Opin Genet Dev 20: 470-477 S0959-437X(10)00103-6 [pii];10.1016/j.gde.2010.06.003 [doi].
42. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3 10.2202/1544-6115.1027 [doi].
43. Bossers K, Ylstra B, Brakenhoff RH, Smeets SJ, Verhaagen J, et al. (2010) Intensity-based analysis of dual-color gene expression data as an alternative to ratio-based analysis to enhance reproducibility. BMC Genomics 11: 112 1471-2164-11-112 [pii];10.1186/1471-2164-11-112 [doi].
44. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
45. Beissbarth T, Speed TP, (2004) GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 20: 1464-1465 10.1093/bioinformatics/bth088 [doi];bth088 [pii].
46. Stam FJ, MacGillavry HD, Armstrong NJ, de Gunst MC, Zhang Y, et al. (2007) Identification of candidate transcriptional modulators involved in successful regeneration after nerve injury. Eur J Neurosci 25: 3629-3637 EJN5597 [pii];10.1111/j.1460-9568.2007.05597.x [doi].
47. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
48. Geffard M, Buijs RM, Seguela P, Pool CW, Le MM (1984) First demonstration of highly specific and sensitive antibodies against dopamine. Brain Res 294: 161-165. 0006-8993(84)91323-4 [pii].
49. Schoffelmeer AN, Drukarch B, De Vries TJ, Hogenboom F, Schetters D, et al. (2011) Insulin modulates cocaine-sensitive monoamine transporter function and impulsive behavior. J Neurosci 31: 1284-1291 31/4/1284 [pii];10.1523/JNEUROSCI.3779-10.2011 [doi].
50. Smidt MP, Burbach JP, (2007) How to make a mesodiencephalic dopaminergic neuron. Nat Rev Neurosci 8: 21-32 nrn2039 [pii];10.1038/nrn2039 [doi].
51. Tepper JM, Lee CR, (2007) GABAergic control of substantia nigra dopaminergic neurons. Prog Brain Res 160: 189-208 S0079-6123(06)60011-3 [pii];10.1016/S0079-6123(06)60011-3 [doi].
52. Schwarzer C, Berresheim U, Pirker S, Wieselthaler A, Fuchs K, et al. (2001) Distribution of the major gamma-aminobutyric acid(A) receptor subunits in the basal ganglia and associated limbic brain areas of the adult rat. J Comp Neurol 433: 526-549.
53. Okada H, Matsushita N, Kobayashi K, Kobayashi K, (2004) Identification of GABAA receptor subunit variants in midbrain dopaminergic neurons. J Neurochem 89: 7-14 10.1111/j.1471-4159.2004.02271.x [doi];JNC2271 [pii].
54. Bustos G, Abarca J, (2004) Campusano J, Bustos V, Noriega V, et al (2004) Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain. Brain Res Brain Res Rev 47: 126-144 S0165017304000578 [pii];10.1016/j.brainresrev.2004.05.002 [doi].
55. Paquet M, Tremblay M, Soghomonian JJ, Smith Y, (1997) AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochemical and in situ hybridization study. J Neurosci 17: 1377-1396.
56. Albers DS, Weiss SW, Iadarola MJ, Standaert DG (1999) Immunohistochemical localization of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits in the substantia nigra pars compacta of the rat. Neuroscience 89: 209-220. S0306452298003285 [pii].
57. Mena-Segovia J, Winn P, Bolam JP, (2008) Cholinergic modulation of midbrain dopaminergic systems. Brain Res Rev 58: 265-271 S0165-0173(08)00023-4 [pii];10.1016/j.brainresrev.2008.02.003 [doi].
58. Saraf A, Virshup DM, Strack S, (2007) Differential expression of the B'beta regulatory subunit of protein phosphatase 2A modulates tyrosine hydroxylase phosphorylation and catecholamine synthesis. J Biol Chem 282: 573-580 M607407200 [pii];10.1074/jbc.M607407200 [doi].
59. Verney C (2003) Phenotypic expression of monoamines and GABA in the early development of human telencephalon, transient or not transient. J Chem Neuroanat 26: 283-292. S0891061803000863 [pii].
60. Ernsberger U (2000) Evidence for an evolutionary conserved role of bone morphogenetic protein growth factors and phox2 transcription factors during noradrenergic differentiation of sympathetic neurons. Induction of a putative synexpression group of neurotransmitter-synthesizing enzymes. Eur J Biochem 267: 6976-6981. ejb1827 [pii].
61. Maden M, (2007) Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 8: 755-765 nrn2212 [pii];10.1038/nrn2212 [doi].
62. Winther M, Berezin V, Walmod PS, (2012) NCAM2/OCAM/RNCAM: cell adhesion molecule with a role in neuronal compartmentalization. Int J Biochem Cell Biol 44: 441-446 S1357-2725(11)00318-9 [pii];10.1016/j.biocel.2011.11.020 [doi].
63. Nishimura-Akiyoshi S, Niimi K, Nakashiba T, Itohara S, (2007) Axonal netrin-Gs transneuronally determine lamina-specific subdendritic segments. Proc Natl Acad Sci U S A 104: 14801-14806 0706919104 [pii];10.1073/pnas.0706919104 [doi].
64. Wartiovaara K, Barnabe-Heider F, Miller FD, Kaplan DR (2002) N-myc promotes survival and induces S-phase entry of postmitotic sympathetic neurons. J Neurosci 22: 815-824. 22/3/815 [pii].
65. Shou J, Rim PC, Calof AL, (1999) BMPs inhibit neurogenesis by a mechanism involving degradation of a transcription factor. Nat Neurosci 2: 339-345 10.1038/7251 [doi].
66. Castro DS, Martynoga B, Parras C, Ramesh V, Pacary E, et al. (2011) A novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targets. Genes Dev 25: 930-945 25/9/930 [pii];10.1101/gad.627811 [doi].
67. Zhao F, Wu T, Lau A, Jiang T, Huang Z, et al. (2009) Nrf2 promotes neuronal cell differentiation. Free Radic Biol Med 47: 867-879 S0891-5849(09)00380-3 [pii];10.1016/j.freeradbiomed.2009.06.029 [doi].
68. Henchcliffe C, Beal MF, (2008) Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 4: 600-609 ncpneuro0924 [pii];10.1038/ncpneuro0924 [doi].